In a patient taking citalopram who is experiencing inner unrest and agitation, what medication should be added to address the agitation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Citalopram-Induced Agitation

Add a low-dose benzodiazepine (lorazepam 0.5-1 mg) as needed for the inner restlessness and agitation, while simultaneously evaluating whether the citalopram dose needs adjustment or whether this represents akathisia requiring specific treatment.

Understanding the Clinical Picture

The symptoms you describe—inner unrest and agitation—are recognized adverse effects of SSRIs including citalopram. The FDA drug label explicitly lists "feeling anxious" and "agitation" as common side effects 1. More concerning, the FDA warns that "anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, and mania" have been reported in patients treated with antidepressants 1. This constellation of symptoms may represent precursors to worsening depression or emerging suicidality, requiring careful evaluation.

Immediate Management Strategy

First-Line Intervention: Benzodiazepines

Lorazepam is the preferred agent for managing SSRI-induced agitation, with strong guideline support:

  • Dosing: Start with lorazepam 0.5-1 mg orally as needed (maximum 4 mg in 24 hours) 2
  • Rationale: Multiple emergency medicine guidelines recommend benzodiazepines (specifically lorazepam or midazolam) as effective monotherapy for acute agitation 3
  • Evidence: Lorazepam demonstrates clinical effectiveness in treating acutely agitated patients across various psychiatric conditions 4

The 2011 geriatric agitation guidelines support oral lorazepam 0.5-1.25 mg with a maximum of 5 mg in 24 hours, noting it can be swallowed or used sublingually 5.

Alternative Considerations

If benzodiazepines are contraindicated or ineffective:

  • Buspirone: For mild to moderate agitation, start 5 mg twice daily (maximum 20 mg three times daily), though it requires 2-4 weeks to become effective 6
  • Mirtazapine: Consider switching to this sedating antidepressant (7.5 mg at bedtime) if the agitation persists, as it promotes sleep and is well-tolerated 6

Critical Differential Diagnosis

Rule Out Akathisia

The description of "inner unrest" is highly suggestive of akathisia—a subjective feeling of restlessness that is a known SSRI side effect 1. This requires different management than simple anxiety:

  • If akathisia is confirmed, consider adding a beta-blocker (propranolol) or reducing the citalopram dose
  • Benzodiazepines can provide symptomatic relief for akathisia as well

Assess for Serotonin Syndrome

The FDA warns about serotonin syndrome presenting with "mental status changes (confusion, agitation, anxiety)" 7. Check for accompanying symptoms:

  • Neuromuscular hyperactivity (tremors, clonus, hyperreflexia)
  • Autonomic hyperactivity (tachycardia, hypertension, diaphoresis)
  • Review all medications for serotonergic interactions

Monitor for Emerging Suicidality

The FDA black box warning emphasizes that agitation may represent a precursor to emerging suicidality 1. Close monitoring is essential, particularly in the first few months of treatment or after dose changes.

Citalopram Dose Considerations

Do not exceed 40 mg daily due to QT prolongation risk 1. The maximum should be limited to 20 mg daily in:

  • Patients >60 years of age
  • CYP2C19 poor metabolizers
  • Those taking CYP2C19 inhibitors (like cimetidine)
  • Patients with hepatic impairment

What NOT to Do

Avoid adding bupropion, as guidelines explicitly state it "should not be used in agitated patients" due to its activating properties 6.

Avoid antipsychotics as first-line unless there is psychosis or severe agitation requiring emergency sedation. While risperidone and other atypicals show efficacy for agitation 8, 9, they carry significant risks including extrapyramidal symptoms and metabolic effects that are not justified for SSRI-induced restlessness.

Follow-Up Plan

  • Reassess in 24-48 hours: If agitation persists despite benzodiazepine use, consider dose reduction or switching antidepressants
  • Gradual discontinuation if needed: The FDA warns about discontinuation syndrome with citalopram, which can include "anxiety, irritability, agitation" 1. Taper gradually if switching medications
  • Document response: Track whether symptoms improve with benzodiazepine alone or require citalopram adjustment

This approach prioritizes patient safety while addressing the immediate symptom burden, recognizing that SSRI-induced agitation represents a potentially serious adverse effect requiring prompt intervention.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.